FR2108847A1 - 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors - Google Patents

5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors

Info

Publication number
FR2108847A1
FR2108847A1 FR7036825A FR7036825A FR2108847A1 FR 2108847 A1 FR2108847 A1 FR 2108847A1 FR 7036825 A FR7036825 A FR 7036825A FR 7036825 A FR7036825 A FR 7036825A FR 2108847 A1 FR2108847 A1 FR 2108847A1
Authority
FR
France
Prior art keywords
pentyl
butyl
dopamene
and5
hydroxylase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7036825A
Other languages
English (en)
Other versions
FR2108847B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to FR7036825A priority Critical patent/FR2108847A1/fr
Publication of FR2108847A1 publication Critical patent/FR2108847A1/fr
Application granted granted Critical
Publication of FR2108847B1 publication Critical patent/FR2108847B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7036825A 1970-10-06 1970-10-06 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors Granted FR2108847A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7036825A FR2108847A1 (en) 1970-10-06 1970-10-06 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7036825A FR2108847A1 (en) 1970-10-06 1970-10-06 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
FR2108847A1 true FR2108847A1 (en) 1972-05-26
FR2108847B1 FR2108847B1 (fr) 1974-03-22

Family

ID=9062618

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7036825A Granted FR2108847A1 (en) 1970-10-06 1970-10-06 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors

Country Status (1)

Country Link
FR (1) FR2108847A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6918507A (fr) * 1969-02-10 1970-08-12

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6918507A (fr) * 1969-02-10 1970-08-12

Also Published As

Publication number Publication date
FR2108847B1 (fr) 1974-03-22

Similar Documents

Publication Publication Date Title
AT327390B (de) Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen
IT1011462B (it) Perfezionamento nelle poltrone da trattamento in particolare per dentisti estetisti e simili
ES414888A1 (es) Metodo de preparar compuestos triciclicos de azufre antia- lergicos.
FI50981C (fi) Menetelmä unilääkkeinä ja rauhoittavina lääkkeinä vaikuttavien s-triat solo-(4,3-a)(1,4)-bentsodiatsepiinien valmistamiseksi.
GB1341794A (en) Medicament for the treatment of hepatic disorders
FR2085630A1 (en) Vincamone compsn - having vasodilator ganglioplegic and antihistamine activity
BE757336A (fr) Compositions therapeutiques comprenant des acides 5-alkylpicoliques a effet hypotenseur (
NL7015792A (en) 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors
FR2108847A1 (en) 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors
FR2059975A1 (en) 1-substd cyclohexane carboxylic acid hydrazides
FI45660C (fi) Menetelmä terapeuttisesti käytettävien D-6-metyyli- ja D-1,6-dimetyyli -8-aminometyyli-ergoliini I N-asyyli-johdannaisten valmistamiseksi.
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.
FR1242M (fr) Médicament, utilisable notamment pour le traitement des affections fongiques, a base de dérivés de la griséofulvine.
AU458749B2 (en) Process for the treatment and care of dentures
NL175382C (nl) Werkwijze ter bereiding van antiflogistisch, analgetisch of antipyretisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van voor gebruik bij die werkwijze geschikte o-anilinofenylaceetamidederivaten.
FR1336M (fr) Médicament anti-inflammatoire et hémostatique, son utilisation comme adjuvant au traitement des infections et compositions thérapeutiques constituées en vue d'une telle utilisation.
IE36780L (en) Pharmaceutical preparations
FR1504117A (fr) Lit, notamment lit d'hôpital
SU510245A1 (ru) Способ лечени фазно-протекающих психозов
FR2092648A1 (en) 2-(fluorophenyl) benzimidazoles - as antiinflammatory and analgesic agents
FR2181653A1 (en) Aminotricyclodecane - dihydroxyphenylalanine compsn - for treating parkinsons disease
CH549382A (de) Handstueck zur zahnaerztlichen behandlung.
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
FR1162M (fr) Médicament applicable dans la thérapeutique de l'hypertension.
FR2035789A1 (en) Acrylic acid derivs with cicatrizant action

Legal Events

Date Code Title Description
ST Notification of lapse